MedPath

UV+AGE DAILY

UV+AGE DAILY

Approved
DIN Number

02526239

Drug Class

Human

Market Date

Jan 24, 2024

Company
HC

vichy canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02526239
AIG Number0761590001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:80.00
Health Canada Classification

ACTIVE INGREDIENTS (7)

AVOBENZONEActive
Strength: 3 % / W/W
Monograph: AVOBENZONE
BEMOTRIZINOLActive
Strength: 5 % / W/W
Monograph: BEMOTRIZINOL
DROMETRIZOLE TRISILOXANEActive
Strength: 7 % / W/W
Monograph: DROMETRIZOLE TRISILOXANE
ENSULIZOLEActive
Strength: 0.5 % / W/W
Monograph: ENSULIZOLE
HOMOSALATEActive
Strength: 2 % / W/W
Monograph: HOMOSALATE
OCTISALATEActive
Strength: 5 % / W/W
Monograph: OCTISALATE
OCTOCRYLENEActive
Strength: 5 % / W/W
Monograph: OCTOCRYLENE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.